D - State of the Art Treatment of DKD

Chronic kidney disease (CKD) and diabetic kidney disease (DKD) remain significant health challenges, affecting millions of adults in the United States. Despite progress in treatment strategies, many patients still face risks of disease progression and cardiovascular complications. This course will explore the latest advancements in managing CKD and DKD, including the integration of new therapies such as sodium-glucose cotransporter-2 (SGLT-2) inhibitors and nonsteroidal mineralocorticoid receptor antagonists (MRAs) into clinical practice. Participants will learn to identify at-risk patients, incorporate cutting-edge treatments, and review emerging data to close the gaps in patient care. Join us to enhance your clinical practice and improve outcomes for patients with CKD and DKD.